The Biotech Growth Trust PLC Strategic Asset Allocation Index
The Biotech Growth Trust PLC strategic asset allocation index. The Biotech Growth Trust PLC (BIOG) has a Strategic Asset Allocation Index of 109.3% as of September 2025. Strategic assets (PP&E of GBX- plus long-term investments of GBX281.77 Million) total GBX281.77 Million, measured against net assets of GBX257.88 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See The Biotech Growth Trust PLC (BIOG) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of The Biotech Growth Trust PLC (2015–2025)
Strategic asset allocation index of The Biotech Growth Trust PLC from 2015 to 2025. This chart shows how The Biotech Growth Trust PLC's Strategic Asset Allocation Index has evolved across 11 annual periods from 2015 to 2025. As of September 2025, the index stands at 109.3%, representing strategic assets of GBX281.77 Million against net assets of GBX257.88 Million GBX. Check tangible net worth ratio of The Biotech Growth Trust PLC to evaluate the tangible quality of the company's equity base.
The Biotech Growth Trust PLC Strategic Asset Allocation Index by Year (2015–2025)
The Biotech Growth Trust PLC strategic asset allocation index by year from 2015 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for The Biotech Growth Trust PLC from 2015 to 2025, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of The Biotech Growth Trust PLC.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 98.6% | GBX218.16 Million | GBX- | GBX218.16 Million | GBX221.21 Million | ▼ -10.6 pp |
| 2024 | 109.3% | GBX394.75 Million | GBX- | GBX394.75 Million | GBX361.31 Million | ▲ +1.1 pp |
| 2023 | 108.2% | GBX357.23 Million | GBX- | GBX357.23 Million | GBX330.29 Million | ▼ -0.3 pp |
| 2022 | 108.4% | GBX427.40 Million | GBX- | GBX427.40 Million | GBX394.21 Million | ▲ +1.5 pp |
| 2021 | 107.0% | GBX643.27 Million | GBX- | GBX643.27 Million | GBX601.47 Million | ▼ -2.1 pp |
| 2020 | 109.0% | GBX398.66 Million | GBX- | GBX398.66 Million | GBX365.57 Million | ▲ +3.6 pp |
| 2019 | 105.5% | GBX431.17 Million | GBX- | GBX431.17 Million | GBX408.88 Million | ▼ -1.3 pp |
| 2018 | 106.8% | GBX445.67 Million | GBX- | GBX445.67 Million | GBX417.40 Million | ▲ +3.9 pp |
| 2017 | 102.9% | GBX461.38 Million | GBX- | GBX461.38 Million | GBX448.41 Million | ▼ -8.2 pp |
| 2016 | 111.1% | GBX420.43 Million | GBX- | GBX420.43 Million | GBX378.57 Million | ▲ +1.7 pp |
| 2015 | 109.4% | GBX583.21 Million | GBX- | GBX583.21 Million | GBX533.30 Million | — |